Leadership Overview
Jamjoom Pharma has 4 executives leading key functions including strategy, finance, and operations.
Driven by a commitment to health, Jamjoom Pharma manufactures and markets pharmaceutical products, over-the-counter medicines, and health-related consumer products across the Afrasia region, impacting markets in the Middle East, Africa, and CIS countries.
Driven by a commitment to health, Jamjoom Pharma manufactures and markets pharmaceutical products, over-the-counter medicines, and health-related consumer products across the Afrasia region, impacting markets in the Middle East, Africa, and CIS countries.
Leadership Roles at Jamjoom Pharma
Tarek Hosni - Chief Executive Officer
Tarek Hosni, the Chief Executive Officer at Jamjoom Pharma, directs the company's overall strategic vision and operational execution. Hosni guides Jamjoom Pharma's expansion across the Middle East, Africa, and CIS countries, ensuring alignment with market demands for pharmaceutical products, OTC medicines, and health-related consumer goods. This leadership role involves fostering innovation in product development and market penetration strategies. By optimizing resource allocation and driving cross-functional collaboration, Tarek Hosni ensures the company's sustained growth and market leadership within the Afrasia region. The Chief Executive Officer's purview extends to maintaining strong relationships with stakeholders and upholding the company's commitment to quality and accessibility in healthcare solutions.
Noor Sheriff - Founder & Chief Executive Officer
Noor Sheriff, the Founder & Chief Executive Officer at Jamjoom Pharma, established the company's foundational principles and continues to shape its strategic direction. Sheriff's vision drives Jamjoom Pharma's mission to provide essential pharmaceutical products, over-the-counter medicines, and health-related consumer products throughout the Middle East, Africa, and CIS regions. This leadership position involves overseeing the company's long-term objectives and ensuring its operations reflect its core values. By championing new initiatives and maintaining a focus on market needs, Noor Sheriff guides the organization's impact on public health and consumer well-being. The Founder & Chief Executive Officer's influence is critical in navigating the dynamic pharmaceutical landscape and securing Jamjoom Pharma's position as a key player in the Afrasia region.
Anwer Mohiuddin - Chief Financial Officer
Anwer Mohiuddin, the Chief Financial Officer at Jamjoom Pharma, manages the company's financial health and strategic fiscal planning. Mohiuddin oversees all financial operations, including budgeting, forecasting, and investment strategies, crucial for Jamjoom Pharma's manufacturing and marketing of pharmaceutical products, OTC medicines, and consumer health goods across the Afrasia region. This role involves ensuring robust financial controls and driving profitability to support expansion in the Middle East, Africa, and CIS countries. By analyzing market trends and optimizing financial performance, Anwer Mohiuddin provides critical insights that inform business decisions and sustain the company's growth trajectory. The Chief Financial Officer's expertise is vital for maintaining fiscal discipline and securing the resources necessary for Jamjoom Pharma's continued success.
Ashraf Hussain - Chief Operating Officer
Ashraf Hussain, the Chief Operating Officer at Jamjoom Pharma, directs the company's day-to-day operational activities and process optimization. Hussain ensures the efficient manufacturing and distribution of pharmaceutical products, over-the-counter medicines, and health-related consumer products across Jamjoom Pharma's key markets in the Middle East, Africa, and CIS countries. This leadership function involves streamlining supply chain logistics and enhancing production capabilities to meet regional demand. By implementing best practices and driving operational excellence, Ashraf Hussain supports the company's commitment to delivering high-quality healthcare solutions. The Chief Operating Officer's focus on operational efficiency is fundamental to Jamjoom Pharma's ability to scale its business and maintain its competitive edge within the Afrasia region.
Explore Leadership Teams in Manufacturing
Founded in 1668 and headquartered in Darmstadt, Germany, Merck KGaA is a multinational pharmaceutical, chemical and life sciences company. Merck operates in Europe, Africa, Asia, Oceania and the Americas. It has major research and development centres in Darmstadt, Boston, Tokyo and Beijing.
Company Leadership GL
JR
Morepen Laboratories is a leading pharmaceutical company specializing in Active Pharmaceutical Ingredients (APIs) and finished formulations. With a commitment to quality and innovation, the company offers a wide range of healthcare, grooming, and OTC products under trusted brands like Dr. Morepen and Gubb World, catering to over 100 million consumers. Morepen has a robust global presence, exporting to over 80 countries and holding certifications from regulatory authorities such as USFDA and WHO GMP. The company is dedicated to enhancing lives through its extensive research and development efforts and state-of-the-art manufacturing facilities.
Company Leadership TA
PM
VK
Hypera SA is a company that operates in the Pharmaceuticals industry. It employs 5000to9999 people and has 1Gto5G of revenue. The company is headquartered in Sao Paulo, Sao Paulo, Brazil.
Company Leadership AR
CA
TR
LM
Samsung Biologics Co.,Ltd. engages in the contract development and manufacturing organization (CDMO) business for biopharmaceuticals products in South Korea, Europe, the United States, and internationally. The company operates in two segments, CDMO, and Biopharmaceutical Development and Commercialization. Its development services include discovery, cell line development, process development, and clinical manufacturing. The company also offers aseptic filling, lyophilization, finishing, storage and shipping, and support services; and quality assurance and control, as well as biosafety and analytical testing services. In addition, it engages in the research and commercialization of biosimilar drugs; development and manufacture of antibody-drug conjugates; and manufactures mammalian and mRNA products. The company was founded in 2011 and is headquartered in Incheon, South Korea.
Company Leadership BB
TK
YK